|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.33 CNY | +3.54% |
|
+2.43% | -39.05% |
| Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
| Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
Jiangsu Yiming Rongyao Medical Technology Co., Ltd signed share transfer agreement to acquire Jiangsu Walvax Biotechnology Co., Ltd. from Walvax Biotechnology Co., Ltd. (SZSE:300142) and Guangzhou Jiahe Biotechnology Co. Ltd. for CNY 290 million on December 31, 2022. As of this announcement date, the Buyer has paid CNY 150,000,000, and Target has completed the change of business registration of its share transfer.
The Buyer will pay the remaining CNY 140,000,000 before April 30, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -39.05% | 3.16B | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| -9.14% | 11.95B | |
| +5.24% | 8.71B | |
| -8.42% | 8.12B |
WALVAX BIOTECHNOLOGY CO., LTD. 
